The following relevant additions and changes to the 1 July 2014 issue of the Schedule of Pharmaceutical Benefits have beed added to MAESTrO Australia:

• Bimatoprost with timolol maleate (Ganfort PF) - new formulation
• Ivermectin (Stromectol) - new indication

Ganfort PF and Stromectol were recommended by the PBAC in March this year.

For more details, go to: http://www.pbs.gov.au/browse/changes